PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Immunobiology, Department of Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT, USA.\', \'Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.\', \'Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT, USA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Data Science Department, Faraday, Inc., Burlington, VT, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.15252/emmm.202115290
?:doi
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 34862752
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
?:title
  • Predicting infectivity: comparing four PCR-based assays to detect culturable SARS-CoV-2 in clinical samples.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all